Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cell characteristics after treatment with either sodium hyaluronate or saline. Cell characteristics after treatment with either sodium hyaluronate or saline.

Published byWilliam Lyons Modified over 5 years ago

Similar presentations

Presentation on theme: "Cell characteristics after treatment with either sodium hyaluronate or saline. Cell characteristics after treatment with either sodium hyaluronate or saline."— Presentation transcript:

1 Cell characteristics after treatment with either sodium hyaluronate or saline.
Cell characteristics after treatment with either sodium hyaluronate or saline. (A) Cytological characteristics before treatment (visit 1): presence of large epithelial cells, showing a polygonal shape and a variable staining cytoplasm and a nucleus/cytoplasm ratio of 1:3 – 1:4; goblet cells are absent. (B). Sodium hyaluronate group after 3 months of treatment (visit 4): presence of both smaller cells with polygonal and round shape and of goblet cells. (C and D) Saline group after 3 months of treatment (visit 4): presence of polygonal cells with keratinised, basophilic cytoplasm with markedly reduced nucleus/cytoplasm; goblet cells are absent. Pasquale Aragona et al. Br J Ophthalmol 2002;86: ©2002 by BMJ Publishing Group Ltd.

Download ppt "Cell characteristics after treatment with either sodium hyaluronate or saline. Cell characteristics after treatment with either sodium hyaluronate or saline."

Similar presentations

Copyright ©2001 BMJ Publishing Group Ltd. Emerg Med J 2001;18:393-395.

Copyright ©2001 BMJ Publishing Group Ltd. Emerg Med J 2001;18:
Daily contribution (%) of sodium and potassium from major food groups among participants aged 8–12 years (n=517), which includes major food groups provided.

Daily contribution (%) of sodium and potassium from major food groups among participants aged 8–12 years (n=517), which includes major food groups provided.
Electron micrographs of the central part of a normal cornea and keratoconus (KC) cornea. Electron micrographs of the central part of a normal cornea and.

Electron micrographs of the central part of a normal cornea and keratoconus (KC) cornea. Electron micrographs of the central part of a normal cornea and.
Demonstration of Helicobacter pylori by the four staining methods: (A) modified Giemsa, (B) anti-H pylori antibody immunostain, (C) modified McMullen's.

Demonstration of Helicobacter pylori by the four staining methods: (A) modified Giemsa, (B) anti-H pylori antibody immunostain, (C) modified McMullen's.
 (A–F) Hairy-cell leukaemia, haematoxylin and eosin (H&E) staining (A) ×40; (B) ×200; (C) TRAP, ×200; (D) CD25, ×200; (E) DBA44, ×200; (F) CD20, ×200.

 (A–F) Hairy-cell leukaemia, haematoxylin and eosin (H&E) staining (A) ×40; (B) ×200; (C) TRAP, ×200; (D) CD25, ×200; (E) DBA44, ×200; (F) CD20, ×200.
 Salmonella enterica serovar typhimurium (S typhimurium) TML interacts at discrete foci with the brush border of human terminal ileal epithelium.  Salmonella.

 Salmonella enterica serovar typhimurium (S typhimurium) TML interacts at discrete foci with the brush border of human terminal ileal epithelium.  Salmonella.
Differential diagnosis for myopic choroidal neovascularisation (CNV): (A and B) haemorrhage due to lacquer cracks; (C) dome-shaped macula with serous retinal.

Differential diagnosis for myopic choroidal neovascularisation (CNV): (A and B) haemorrhage due to lacquer cracks; (C) dome-shaped macula with serous retinal.
Late fluorescein angiograms of the right macula taken at 13 minutes.

Late fluorescein angiograms of the right macula taken at 13 minutes.
Subjective quality of vision recorded by the patient during a typical menstrual cycle superimposed on a graph of levels of the principal female hormones.

Subjective quality of vision recorded by the patient during a typical menstrual cycle superimposed on a graph of levels of the principal female hormones.
A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.

A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.
Masashi Maeda et al. Heart Asia 2013;5:7-14

Masashi Maeda et al. Heart Asia 2013;5:7-14
Subgroup analysis of the 17 trials comparing haloperidol and placebo in schizophrenia (outcome: response rate). Subgroup analysis of the 17 trials comparing.

Subgroup analysis of the 17 trials comparing haloperidol and placebo in schizophrenia (outcome: response rate). Subgroup analysis of the 17 trials comparing.
Occurrence of falls in the past year on the basis of the set of risk factors (poor self rated health, poor cognitive status, impaired ADL, two or more.

Occurrence of falls in the past year on the basis of the set of risk factors (poor self rated health, poor cognitive status, impaired ADL, two or more.
A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.

A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.
Eye movement record showing horizontal and vertical traces of the right (R) and left (L) eyes with the Ober-2 system. Eye movement record showing horizontal.

Eye movement record showing horizontal and vertical traces of the right (R) and left (L) eyes with the Ober-2 system. Eye movement record showing horizontal.
Kaplan-Meier survival curve for unloader brace—Kaplan-Meier survival analysis demonstrated rapid conversion to TKR for the first 12 months, which then.

Kaplan-Meier survival curve for unloader brace—Kaplan-Meier survival analysis demonstrated rapid conversion to TKR for the first 12 months, which then.
Trial design. Study design schematic of the PF-ILD trial followed by a separate open-label trial (optional): part A (visits 1 through 9 over 52 weeks)

Trial design. Study design schematic of the PF-ILD trial followed by a separate open-label trial (optional): part A (visits 1 through 9 over 52 weeks)
Risk of having any adverse effects with supplements compared with placebo. Risk of having any adverse effects with supplements compared with placebo. Stratified.

Risk of having any adverse effects with supplements compared with placebo. Risk of having any adverse effects with supplements compared with placebo. Stratified.
Receiver operating characteristic (ROC) curves for the AIMS65 score and Glasgow–Blatchford score (GBS) as predictors of requirement for blood transfusion.

Receiver operating characteristic (ROC) curves for the AIMS65 score and Glasgow–Blatchford score (GBS) as predictors of requirement for blood transfusion.
Receiver operating characteristic (ROC) curves for the AIMS65 score and Glasgow–Blatchford score (GBS) as predictors of requirement for high dependency.

Receiver operating characteristic (ROC) curves for the AIMS65 score and Glasgow–Blatchford score (GBS) as predictors of requirement for high dependency.

Similar presentations

Ads by Google